{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:28:37Z","timestamp":1792718917227,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"\n Purpose:<\/jats:title>\n The primary objective was to evaluate the clinical response of refractory cases of fungal keratitis to topical 1% posaconazole therapy.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Prospective longitudinal non-randomized open label dual-cohort study of 70 eyes of refractory fungal keratitis, 35 were recruited as posaconazole treatment (PCZ) group for topical 1% posaconazole therapy and compared to 35 eyes on conventional antifungal therapy. Study parameters included demographic and treatment details, visual acuity, comprehensive slit-lamp biomicroscopy, clinical photography, ASOCT at recruitment and weekly (week 1, 2, 3 and 4 after treatment initiation). Clinical assessment included keratitis severity grade, time of healing, and healing response. Anti-fungal susceptibility testing was performed.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n The mean age of 35 patients recruited in the PCZ treatment group was 45 \u00b1 17.32 years and that for the conventional treatment group was 43.22 \u00b1 15.04 years. Culture isolation was possible in 25 eyes (71.4%) in the PCZ treatment group, with\n Fusarium<\/jats:italic>\n and\n Aspergillus<\/jats:italic>\n spp. being the most common cornea pathogenic mycotic organisms. The mean healing time in the PCZ group was 27.13 \u00b1 5.8 days and in the conventional treatment group was 26.41 \u00b1 4.81 days. Healing response in the PCZ treatment showed that 27 eyes (77.14%) had healed, 3 (8.5%) had delayed healing, and 5 (14.28%) required therapeutic keratoplasty, whereas in the conventional treatment group, 26 (74.28%) healed, 2 (5.7%) had delayed healing, and 7 (20%) needed keratoplasty (\n P<\/jats:italic>\n = 0.65, 0.72, 0.54, respectively). Topical 1% PCZ therapy of chronic mycotic keratitis was helpful in resolution in 85.7% of cases (30 eyes) with five eyes needing surgical intervention, which was comparable to that of conventional antimycotic therapy cohorts.\n Fusarium<\/jats:italic>\n isolates showed greater susceptibility to natamycin in our study per MIC\n 50<\/jats:sub>\n values, with susceptibility to the common antimycotic agents varying between the\n Aspergillus<\/jats:italic>\n spp. in both PCZ treatment and conventional treatment groups. All isolates showed minimal values of MIC-\n 50<\/jats:sub>\n with PCZ. Antifungal susceptibility testing in our study recruits showed that about 90% of the\n Fusarium<\/jats:italic>\n spp. isolates to be best responsive to natamycin and PCZ, whereas\n Aspergillus niger<\/jats:italic>\n isolates were sensitive to voriconazole, itraconazole, amphotericin B, and PCZ,\n Aspergillus flavus<\/jats:italic>\n to voriconazole and PCZ,\n Aspergillus fumigatus<\/jats:italic>\n to both polyenes and triazoles.\n Cladosporium<\/jats:italic>\n spp. were best sensitive to natamycin and PCZ,\n Penicillium<\/jats:italic>\n spp. to natamycin and azoles. Alternaria keratitis isolates were sensitive to voriconazole and PCZ, whereas\n Rhizopus<\/jats:italic>\n isolate was best sensitive to PCZ.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n \n Topical 1% PCZ therapy in refractory fungal keratitis was comparable to that of conventional antimycotic agents, with lower MIC-\n 50<\/jats:sub>\n against the common pathogenic fungi as compared to natamycin, amphotericin B, and voriconazole.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijo.ijo_1811_24","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T03:01:29Z","timestamp":1734922889000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of topical 1% posaconazole therapy in refractory fungal keratitis"],"prefix":"10.4103","volume":"73","author":[{"given":"Murugesan","family":"Vanathi","sequence":"first","affiliation":[{"name":"Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra K","family":"Yadav","sequence":"additional","affiliation":[{"name":"Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumurthy","family":"Velpandian","sequence":"additional","affiliation":[{"name":"Ocular Pharmacology Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishat Hussain","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Ocular Microbiology Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Muraleekrishna","sequence":"additional","affiliation":[{"name":"Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Beniwal","sequence":"additional","affiliation":[{"name":"Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neiwete","family":"Lomi","sequence":"additional","affiliation":[{"name":"Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noopur","family":"Gupta","sequence":"additional","affiliation":[{"name":"Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Tandon","sequence":"additional","affiliation":[{"name":"Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroof A","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"R1-20260424","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jop.2018.0089","article-title":"Challenges in the polyene- and azole-based pharmacotherapy of ocular fungal infections","volume":"35","author":"Lakhani","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"R2-20260424","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/bjo.2007.136515","article-title":"Voriconazole in the treatment of fungal eye infections: A review of current literature","volume":"92","author":"Hariprasad","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R3-20260424","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/ICO.0000000000002550","article-title":"Tintelnotia destructans Keratitis: A clinicopathological report and review of the literature","volume":"40","author":"Kaufmann","year":"2021","journal-title":"Cornea"},{"key":"R4-20260424","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myac024","article-title":"Elucidating the clinical, microbiological and molecular diagnostic aspects of Macrophomina phaseolina keratitis","author":"Ahirwar","year":"2022","journal-title":"Med Mycol"},{"key":"R5-20260424","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.86.7.829-a","article-title":"Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis","volume":"86","author":"Sponsel","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R6-20260424","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/ICO.0000000000002832","article-title":"High-dose oral posaconazole for the treatment of recalcitrant fungal keratitis","volume":"41","author":"Ferguson","year":"2022","journal-title":"Cornea"},{"key":"R7-20260424","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1186\/s12348-023-00380-z","article-title":"Three cases of recalcitrant Paecilomyces keratitis in Southern California within a short period","volume":"14","author":"Kim","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R8-20260424","doi-asserted-by":"crossref","first-page":"e228645.","DOI":"10.1136\/bcr-2018-228645","article-title":"Posaconazole in the treatment of refractory Purpureocillium lilacinum (former Paecilomyces lilacinus) keratitis: The salvation when nothing works","volume":"12","author":"Almeida Oliveira","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R9-20260424","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/ICO.0b013e3180de4953","article-title":"Recalcitrant Beauveria bassiana keratitis: Confocal microscopy findings and treatment with posaconazole (Noxafil)","volume":"26","author":"Tu","year":"2007","journal-title":"Cornea"},{"key":"R10-20260424","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/ICO.0000000000000143","article-title":"Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole","volume":"33","author":"Arnoldner","year":"2014","journal-title":"Cornea"},{"key":"R11-20260424","first-page":"701653.","article-title":"Effectiveness of posaconazole in recalcitrant fungal keratitis resistant to conventional antifungal drugs","volume":"2014","author":"Altun","year":"2014","journal-title":"Case Rep Ophthalmol Med"},{"key":"R12-20260424","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.oftal.2014.02.020","article-title":"Keratitis caused by Absidia corymbifera in an immunocompetent male with no corneal injuries","volume":"90","author":"Mesa Varona","year":"2015","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R13-20260424","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s13346-021-00974-x","article-title":"Posaconazole micelles for ocular delivery: In vitro permeation, ocular irritation and antifungal activity studies","volume":"12","author":"Durgun","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"R14-20260424","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.4103\/ijo.IJO_855_22","article-title":"Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India","volume":"70","author":"Vanathi","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"R15-20260424","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/02713683.2020.1749669","article-title":"Corneal pharmacokinetics of voriconazole and posaconazole following intrastromal injection and posaconazole eye drops instillation in rats","volume":"45","author":"Gueudry","year":"2020","journal-title":"Curr Eye Res"},{"key":"R16-20260424","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1099\/mic.0.000927","article-title":"Transcriptional response of Fusarium oxysporumand Neocosmospora solani challenged with amphotericin B or posaconazole","volume":"166","author":"Castillo-Casta\u00f1eda","year":"2020","journal-title":"Microbiology (Reading)"},{"key":"R17-20260424","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0301-4738.83614","article-title":"Molecular characterization of drug-resistant and drug-sensitive Aspergillus isolates causing infectious keratitis","volume":"59","author":"Nayak","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"R18-20260424","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archopht.125.6.789","article-title":"Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis","volume":"125","author":"Lalitha","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R19-20260424","first-page":"537","article-title":"Grading corneal ulcers","volume":"7","author":"Harrison","year":"1975","journal-title":"Ann Ophthalmol"},{"key":"R20-20260424","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/myc.12306","article-title":"Filamentous fungal infections of the cornea: A global overview of epidemiology and drug sensitivity","volume":"58","author":"Kredics","year":"2015","journal-title":"Mycoses"},{"key":"R21-20260424","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaophthalmol.2016.0530","article-title":"Changing azole resistance: A secondary analysis of the MUTT I randomized clinical trial","volume":"134","author":"Prajna","year":"2016","journal-title":"JAMA Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1811_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:52:21Z","timestamp":1786647141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1811_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1811_24","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"2024-07-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}